MLTXMoonLake Immunotherapeutics
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−28% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −28% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 10% since the previous count, up from 7.7% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MLTX is trading
MoonLake Immunotherapeutics is +27% over the past year while the S&P 500 is +16%: 11 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −28%
vs 200-day average · a clear downtrend
- RSI (14)
- 54
RSI (14) · neutral
- Below its 52-week high
- 46%
Below its 52-week high
Details›
- Last close2026-10-23
- $11.87
- 1 monthS&P 500 −0.94%
- −2.1%
- 1 yearS&P 500 +16%
- +27%
- 5 yearsS&P 500 +86%
- +19%
- vs 50-day average$12.97
- −8.5%
- 52-week high
- $22.16
- 52-week low
- $9.12
- Annualised volatility
- 92%
| Year | Return |
|---|---|
| 2026 (year to date) | −9.9% |
| 2025 | −76% |
| 2024 | −10% |
| 2023 | +475% |
| 2022 | +6.2% |
| 2021 | −13% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | +1.1% |
| Feb | 6 | 3 of 6 | +8.4% |
| Mar | 6 | 4 of 6 | +3.3% |
| Apr | 6 | 1 of 6 | −11% |
| May | 6 | 3 of 6 | +10% |
| Jun | 6 | 5 of 6 | +15% |
| Jul | 6 | 3 of 6 | +5.5% |
| Aug | 6 | 3 of 6 | +4.2% |
| Sep | 6 | 2 of 6 | −18% |
| Oct | 6 | 4 of 6 | +5.3% |
| Nov | 6 | 4 of 6 | +9.9% |
| Dec | 6 | 3 of 6 | +7.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.